5-HT2C receptor modulation and the treatment of obesity

Diabetes Obes Metab. 1999 Jul;1(4):207-14. doi: 10.1046/j.1463-1326.1999.00037.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Appetite Depressants / pharmacology
  • Appetite Depressants / therapeutic use*
  • Cyclobutanes / therapeutic use
  • Disease Models, Animal
  • Fenfluramine / pharmacology
  • Fenfluramine / therapeutic use*
  • Humans
  • Obesity / drug therapy*
  • Receptor, Serotonin, 5-HT2C
  • Receptors, Serotonin / drug effects
  • Receptors, Serotonin / physiology*
  • Selective Serotonin Reuptake Inhibitors / therapeutic use

Substances

  • Appetite Depressants
  • Cyclobutanes
  • Receptor, Serotonin, 5-HT2C
  • Receptors, Serotonin
  • Serotonin Uptake Inhibitors
  • Fenfluramine
  • sibutramine